Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America

Clinical Therapeutics
Remo SusannaLatin American Glaucoma Society

Abstract

The newer ocular hypotensive agents available to treat glaucoma and ocular hypertension (OHT) include latanoprost, a prostaglandin F(2alpha) analogue, and the fixed combination of dorzolamide hydrochloride, a carbonic anhydrase inhibitor, and timolol maleate, a beta-blocker. The aim of this study was to compare the efficacy and tolerability of latanoprost with that of the fixed combination of dorzolamide and timolol over 8 weeks. This interventional, 8-week, randomized, open-label, parallel-group study was conducted at 18 centers in 6 Latin American countries. Patients with unilateral or bilateral primary open-angle, pigmentary, or exfoliative glaucoma or OHT were randomized to receive latanoprost, 1 drop in the affected eye QD (evening), or fixed-combination dorzolamide/timolol, 1 drop in the affected eye BID (morning and evening). Medications were self-administered, 1 drop per affected eye. At baseline and week 8, intraocular pressure (IOP) was measured 3 times each at 8:30 am, 10:00 am, 2:00 pm, and 5:00 pm and after the water-drinking test, which estimates the IOP peak of diurnal tension curve, performed following the 5:00 pm IOP assessment. The primary efficacy outcome was change in diurnal IOP (the mean of IOP measurement...Continue Reading

References

Jun 1, 1980·Archives of Internal Medicine·N B Charan, S Lakshminarayan
Aug 15, 1993·American Journal of Ophthalmology·W C StewartG Sethuraman
Aug 1, 1997·Cellular and Molecular Life Sciences : CMLS·G J Amabeoku, J A Syce
Feb 27, 2001·Current Opinion in Ophthalmology·I GriersonN Pfeiffer
Sep 3, 2002·Survey of Ophthalmology·Lill-Inger LarssonLuca Rossetti
Aug 1, 1964·American Journal of Ophthalmology·D MILLER

❮ Previous
Next ❯

Citations

Oct 18, 2007·Journal of Community Health·Kimberly GentryThomas A Arcury
Jan 3, 2006·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Hiroshi SakaiShoichi Sawaguchi
Feb 24, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Jin-Wei ChengYou Li
Dec 14, 2011·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Delan JinapriyaYvonne M Buys
Feb 22, 2011·American Journal of Ophthalmology·Carlos Gustavo V De MoraesRobert Ritch
Aug 15, 2008·Clinical & Experimental Ophthalmology·Jennifer C Fan, Charles N J McGhee
May 29, 2009·Clinical & Experimental Ophthalmology·Carlos Gustavo V De MoraesRemo Susanna
Sep 27, 2012·Clinical & Experimental Ophthalmology·Marcelo HatanakaRemo Susanna
Sep 13, 2014·Clinical & Experimental Ophthalmology·Mirko BabicRemo Susanna
Aug 3, 2005·Ophthalmology·Felipe A Medeiros, Remo Susanna
Aug 11, 2015·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Verena Ribeiro JuncalTiago Santos Prata
Feb 7, 2017·Clinical & Experimental Ophthalmology·Remo SusannaMarcelo Hatanaka
Mar 4, 2005·Current Opinion in Ophthalmology·Jonathan G Crowston, Robert N Weinreb
Apr 13, 2018·The Annals of Pharmacotherapy·Eileen M StockLaurel A Copeland
May 21, 2015·The Australian and New Zealand Journal of Psychiatry·Jiansong ZhouSeena Fazel
Jan 8, 2009·The Annals of Pharmacotherapy·Bradley C MartinBetsy Lynn Sleath
Sep 9, 2008·The Australian and New Zealand Journal of Psychiatry·Amanda WheelerElizabeth Robinson
Dec 2, 2008·Conservation Biology : the Journal of the Society for Conservation Biology·Corina J RahmigKimberly A With
Feb 12, 2009·Acta Psychiatrica Scandinavica·N M MenezesR B Zipursky
Apr 16, 2009·Journal of Evaluation in Clinical Practice·Amanda WheelerPeter Joyce
Aug 29, 2009·CNS Neuroscience & Therapeutics·T Michael KashnerA John Rush
Aug 20, 2009·Journal of Renal Care·Melissa ChamneyTheodora Kafkia
Aug 25, 2009·International Journal of Methods in Psychiatric Research·T Michael KashnerA John Rush
Oct 15, 2009·International Endodontic Journal·I A Ahmad
Jul 5, 2018·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Martin Q Diep, Michele C Madigan
Jan 7, 2010·Perspectives in Psychiatric Care·Esther L MeerwijkMieke Grypdonck
Jun 10, 2010·Journal of Psychiatric and Mental Health Nursing·H HätönenM Välimäki
Jun 2, 2005·The British Journal of Sociology·Michael Burawoy
Jul 8, 2005·Expert Review of Proteomics·Julia Tait LathropDavid J Hammond
Jul 7, 2005·Journal of Medical Internet Research·Amanda L Graham, David B Abrams
Jul 20, 2005·Research in Nursing & Health·Victoria ChampionUsha Menon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.